Purpose:The presenting clinico-hematologic features of1,283 patientswith IgGand IgAmonoclonal gammopathies of undetermined significance (MGUS) were correlated with the frequency of evolution into multiple myeloma (MM). Experimental Design: Two IgGMGUS populations were evaluated: a training sample (553 patients) and a test sample (378 patients); the IgAMGUS population consisted of 352 patients. Results: Forty-seven of the 553 training group patients and 22 of 378 test group IgG patients developed MMafter a median follow-up of 6.7 and 3.6 years, respectively. Multivariate analysis showed that serum monoclonal component (MC) levels of ≤1.5 g/dL, the absence of light-chain proteinuria and normal serumpolyclonal immunoglobulinlevels defined a prognostically favorable subset of patients, and could be used to stratify the patients into three groups at different10-year risk of evolution (hazard ratio, 1.0, 5.04, 11.2; P < 0.001).This scoring system was validated in the test sample.Thirty of the 352 IgA patients developed MMafter a median follow-up of 4.8 years, and multivariate analysis showed that hemoglobin levels of <12.5 g/dL and reduced serumpolyclonal immunoglobulin correlated with progression. A pooled statistical analysis of all of the patients confirmed the validity ofMayo Clinic riskmodel showing that IgAclass, serumMClevels, and light-chain proteinuria are the most important variables correlated with disease progression. Conclusions: Using simple variables, we validated a prognostic model for IgGMGUS. Among the IgA cases, the possible prognostic role of hemoglobin emerged in addition to a decrease in normal immunoglobulin levels.

Prognostic scoring system for IGG and IGA monoclonal gammopathies of undetermined significance / F. Rossi, M.T. Petrucci, A. Guffanti, L. Marcheselli, D. Rossi, V. Callea, F. Vincenzo, M. De Muro, A. Baraldi, O. Villani, P. Musto, A. Bacigalupo, G. Gaidiano, G. Avvisati, M. Goldaniga, L. De Poli, L. Baldini. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 94:Suppl. 2(2009), pp. 89-89. ((Intervento presentato al 42. convegno Congress of the Italian Society of Hematology tenutosi a Milan, Italy nel 2009 [10.1158/1078-0432.CCR-08-3150].

Prognostic scoring system for IGG and IGA monoclonal gammopathies of undetermined significance

F. Rossi
Primo
;
L. Baldini
Ultimo
2009

Abstract

Purpose:The presenting clinico-hematologic features of1,283 patientswith IgGand IgAmonoclonal gammopathies of undetermined significance (MGUS) were correlated with the frequency of evolution into multiple myeloma (MM). Experimental Design: Two IgGMGUS populations were evaluated: a training sample (553 patients) and a test sample (378 patients); the IgAMGUS population consisted of 352 patients. Results: Forty-seven of the 553 training group patients and 22 of 378 test group IgG patients developed MMafter a median follow-up of 6.7 and 3.6 years, respectively. Multivariate analysis showed that serum monoclonal component (MC) levels of ≤1.5 g/dL, the absence of light-chain proteinuria and normal serumpolyclonal immunoglobulinlevels defined a prognostically favorable subset of patients, and could be used to stratify the patients into three groups at different10-year risk of evolution (hazard ratio, 1.0, 5.04, 11.2; P < 0.001).This scoring system was validated in the test sample.Thirty of the 352 IgA patients developed MMafter a median follow-up of 4.8 years, and multivariate analysis showed that hemoglobin levels of <12.5 g/dL and reduced serumpolyclonal immunoglobulin correlated with progression. A pooled statistical analysis of all of the patients confirmed the validity ofMayo Clinic riskmodel showing that IgAclass, serumMClevels, and light-chain proteinuria are the most important variables correlated with disease progression. Conclusions: Using simple variables, we validated a prognostic model for IgGMGUS. Among the IgA cases, the possible prognostic role of hemoglobin emerged in addition to a decrease in normal immunoglobulin levels.
Settore MED/15 - Malattie del Sangue
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/71839
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact